Pharmabiz3h
CAGE Bio begins phase 2b clinical trial for CGB-500, a breakthrough topical JAK inhibitor for moderate to severe atopic dermatitis
CAGE Bio begins phase 2b clinical trial for CGB-500, a breakthrough topical JAK inhibitor for moderate to severe atopic dermatitis: San Carlos, California Saturday, January 11, 20 ...
Pharmabiz4h
FORE Biotherapeutics highlights pipeline achievements for its oncology programme; Provides objectives for 2025
FORE Biotherapeutics highlights pipeline achievements for its oncology programme; Provides objectives for 2025: Philadelphia Saturday, January 11, 2025, 17:00 Hrs [IST] FORE Bioth ...
Pharmabiz5h
Newron Pharma, Myung In Pharm ink license agreement to develop, manufacture & commercialize Newron’s evenamide in South Korea
Newron Pharma, Myung In Pharm ink license agreement to develop, manufacture & commercialize Newron’s evenamide in South Korea: Milan Saturday, January 11, 2025, 16:00 Hrs [IST] ...
Pharmabiz6h
SynCardia Systems gets CNIPA notification granting first patent covering company’s next-generation total artificial heart
SynCardia Systems gets CNIPA notification granting first patent covering company’s next-generation total artificial heart: Tucson, Arizona Saturday, January 11, 2025, 15:00 Hrs ...
Pharmabiz7h
Gaelic Labs establishes subsidiary in UAE, enabling access to growing Middle East pharma market
Gaelic Labs establishes subsidiary in UAE, enabling access to growing Middle East pharma market: Ireland Saturday, January 11, 2025, 13:30 Hrs [IST] Gaelic Laboratories, a Europea ...
Pharmabiz7h
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology: Ingelheim Saturday, January 11, 2025, 14:00 Hrs [IST] Boehringer Ingelheim and Synaf ...
Pharmabiz5d
Bayer announces Federal Court of Australia brings an end to Roundup litigation
The Federal Court of Australia brought an end to the last Roundup case in Australia, closing all pending injury litigation there. The Court granted the plaintiffs’ request to discontinue the Fenton ...
Pharmabiz5d
KPRDO seeks Centre’s intervention to for reimbursement on cut strips of expiry dated medicines
The Karnataka Pharma Retailers & Distributors Organization (KPRDO) has urged the Union health ministry for reimbursement for cut strips of expiry dated medicines. In a communication to the Ministry ...
Pharmabiz5d
CDSCO releases draft standard evaluation protocols for issuing license for IVDs
The Central Drugs Standard Control Organisation (CDSCO) and Indian Council of Medical Research (ICMR) have together released the draft standard evaluation protocols for the purpose of issuing license ...
Pharmabiz5d
CIPI chairman says the pharma MSME sector had expected unconditional extension and financial aid from the government
Responding to the draft notification issued by the union health ministry last Saturday, the chairman of the Confederation of Indian Pharmaceutical Industries (CIPI), R K Jain, has commented that the ...
Pharmabiz5d
Indian pharma needs regulations of less prescriptive nature: Dr DBA Narayana
Indian pharmaceutical companies are operating in a highly regulated environment, with rules and compliance standards often being prescriptive. While these regulations are essential to ensure quality, ...
Pharmabiz5d
TN pharma fully prepared for audit of drug control department as per revised Schedule M: TN IDMA
Pharmaceutical companies in Tamil Nadu are now fully prepared for the revised Schedule M audit of the drug control department as all the small scale units have upgraded their manufacturing facilities ...